Dysplasia of the uterine cervix. Incidence of regression, recurrence, and cancer

E. Stern,P. M. Neely

DOI: https://doi.org/10.1002/1097-0142(196404)17:4<508::AID-CNCR2820170412>3.0.CO;2-S

IF: 6.9209

1964-04-01

Cancer

Abstract:From the Department of Pathology, University of California School of Medicine, The Center for the Health Sciences, Los Angeles 24, Calif. This study was carried out at the Cancer Detection Center, Los Angeles, Calif., where it was supported in part by a grant (NC-FIDB CS-9729) from the National Cancer Institute, of the National Institutes of Health, Public Health Service. The authors are indebted to Dr. Nancy P. Menoher for her co-operation as Head of the follow-up Gynecology Clinic. The authors also wish to acknowledge the technical assistance of Claire McLatchie, C.T. * Present address: School of Public Health, University of California at Los Angeles, Los AngeIes 24, Calif. t Present address: Biological Sciences Computation Center, University of Chicago, Chicago, Ill. Received for publication Sept. 24, 1963. very few were found in the much larger fraction of the population who had not shown dysplasia. Further, individuals with dysplasia of the cervix detected during mass screening for cancer and then kept under observation constituted a high-risk group for cervical cancer.6 The present study evaluates the group with dysplasia with respect to the status of the dysplastic lesion at uniform intervals of time during a follow-up study and makes use of this information for the estimation of incidence rates. During the course of follow-up, variability in the diagnosis was noted, ranging from absence of the dysplasia lesion to the presence of cancer. These changes in diagnosis are considered indicative of regression and progression of the dysplasia. We are aware, of course, that disappearance may be incorrectly assumed simply on the basis of failure to observe cells characteristic of dysplasia. Study of the pattern of variability in a